Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein. - PubMed - NCBI

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein. - PubMed - NCBI

Biomed Res Int. 2017;2017:9359276. doi: 10.1155/2017/9359276. Epub 2017 Jan 22.

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.

Rekstin A1, Isakova-Sivak I1, Petukhova G1, Korenkov D1, Losev I1, Smolonogina T1, Tretiak T1, Donina S1, Shcherbik S2, Bousse T2, Rudenko L1.

Author information

Abstract

Since conserved viral proteins of influenza virus, such as nucleoprotein (NP) and matrix 1 protein, are the main targets for virus-specific CD8+ cytotoxic T-lymphocytes (CTLs), we hypothesized that introduction of the NP gene of wild-type virus into the genome of vaccine reassortants could lead to better immunogenicity and afford better protection. This paper describes in vitro and in vivo preclinical studies of two new reassortants of pandemic H1N1 live attenuated influenza vaccine (LAIV) candidates. One had the hemagglutinin (HA) and neuraminidase (NA) genes from A/South Africa/3626/2013 H1N1 wild-type virus on the A/Leningrad/134/17/57 master donor virus backbone (6 : 2 formulation) while the second had the HA, NA, and NP genes of the wild-type virus on the same backbone (5 : 3 formulation). Although both LAIVs induced similar antibody immune responses, the 5 : 3 LAIV provoked greater production of virus-specific CTLs than the 6 : 2 variant. Furthermore, the 5 : 3 LAIV-induced CTLs had higher in vivo cytotoxic activity, compared to 6 : 2 LAIV. Finally, the 5 : 3 LAIV candidate afforded greater protection against infection and severe illness than the 6 : 2 LAIV. Inclusion in LAIV of the NP gene from wild-type influenza virus is a new approach to inducing cross-reactive cell-mediated immune responses and cross protection against pandemic influenza.

PMID:

 

28210631

 

PMCID:

 

PMC5292185

 

DOI:

 

10.1155/2017/9359276

[PubMed - indexed for MEDLINE] 

Free PMC Article

https://phgkb.cdc.gov/GAPPKB/phgHome.do






Last Posted: Feb 23, 2017

---

• Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein. 
  Rekstin Andrey et al. BioMed research international 2017 20179359276
• Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015.  
  Rash Adam et al. Pathogens (Basel, Switzerland) 2017 Feb (1)
• Genesis and Dissemination of Highly Pathogenic H5N6 Avian Influenza Viruses.  
  Yang Lei et al. Journal of virology 2017 Mar (5)
• Bayesian phylogeography of influenza A/H3N2 for the 2014-15 season in the United States using three frameworks of ancestral state reconstruction. 
  Magee Daniel et al. PLoS computational biology 2017 Feb (2) e1005389
• The effective rate of influenza reassortment is limited during human infection.  
  Sobel Leonard Ashley et al. PLoS pathogens 2017 Feb (2) e1006203
• A universal computational model for predicting antigenic variants of influenza A virus based on conserved antigenic structures.  
  Peng Yousong et al. Scientific reports 2017 Feb 42051
• A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses. 
  McClain Micah T et al. Open forum infectious diseases 2016 Jan (1) ofw007
• Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.  
  Alan Hampson et al. Vaccine 2017 Jan
• Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.  
  Debbink Kari et al. PLoS pathogens 2017 Jan (1) e1006194
• Reassortment between Swine H3N2 and 2009 Pandemic H1N1 in the United States Resulted in Influenza A Viruses with Diverse Genetic Constellations with Variable Virulence in Pigs.  
  Rajão Daniela S et al. Journal of virology 2017 Feb (4)
• Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.  
  Trebbien Ramona et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2017 Jan (3)
• Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014.  
  Oong Xiang Yong et al. PloS one 2017 (1) e0170610
• Reverse Genetics Approaches for the Development of Influenza Vaccines.  
  Nogales Aitor et al. International journal of molecular sciences 2016 Dec (1)
• Haemagglutinin and neuraminidase sequencing delineate nosocomial influenza outbreaks with accuracy equivalent to whole genome sequencing.  
  Houghton Rebecca et al. The Journal of infection 2017 Jan
• Bayesian nonparametric clustering in phylogenetics: modeling antigenic evolution in influenza.  
  Cybis Gabriela B et al. Statistics in medicine 2017 Jan
• Influenza virus exploits tunneling nanotubes for cell-to-cell spread.  
  Kumar Amrita et al. Scientific reports 2017 Jan 740360

more